William Ho, Chief Medical Officer at RAPT Therapeutics, Inc. (RAPT), sold 2,000 shares at $39.06 ($78K) on 2021-09-17, disclosed to the SEC on 2021-09-20.
Scheduled sale ($78k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.86 | 302 | $12K | 15.1% |
| 2 | $38.86 | 616 | $24K | 30.7% |
| 3 | $38.88 | 33 | $1K | 1.6% |
| 4 | $38.96 | 3 | $117 | 0.1% |
| 5 | $39.06 | 1,046 | $41K | 52.4% |
| Total | $38.97 avg | 2,000 |
| $78K |
| 100% |
| Filing → |
| RAPT | SELL | 2023-10-04 | $39K | — | Filing → |
| RAPT | SELL | 2023-08-22 | $47K | — | Filing → |
| RAPT | SELL | 2023-04-20 | $94K | — | Filing → |